SUPPLEMENTAL FINANCIAL INFORMATION
STOCK-BASED COMPENSATION EXPENSE
(Unaudited, in thousands)
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||
Cost of revenue | $ | 1,198 | $ | 885 | $ | 2,505 | $ | 1,700 | ||||||||
Research and development | 9,187 | 6,752 | 17,588 | 12,918 | ||||||||||||
Selling, general and administrative | 32,530 | 24,489 | 62,633 | 46,092 | ||||||||||||
Total stock-based compensation expense | $ | 42,915 | $ | 32,126 | $ | 82,726 | $ | 60,710 | ||||||||
RECONCILIATION OF NET INCOME TO NON-GAAP NET INCOME
(Unaudited, in thousands, except per share amounts)
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||
Net income | $ | 114,679 | $ | 55,169 | $ | 194,245 | $ | 100,582 | ||||||||
Adjustments to reconcile net income to non-GAAP net income: | ||||||||||||||||
Stock-based compensation expense | 42,915 | 32,126 | 82,726 | 60,710 | ||||||||||||
Amortization of purchased intangible assets | 33 | - | 66 | - | ||||||||||||
Deferred compensation plan expense (income) | (302 | ) | 290 | (475 | ) | 233 | ||||||||||
Tax effect | (314 | ) | (1,117 | ) | (1,276 | ) | (5,578 | ) | ||||||||
Non-GAAP net income | $ | 157,011 | $ | 86,468 | $ | 275,286 | $ | 155,947 | ||||||||
Non-GAAP net income per share: | ||||||||||||||||
Basic | $ | 3.36 | $ | 1.89 | $ | 5.91 | $ | 3.42 | ||||||||
Diluted | $ | 3.25 | $ | 1.81 | $ | 5.70 | $ | 3.27 | ||||||||
Shares used in the calculation of non-GAAP net income per share: | ||||||||||||||||
Basic | 46,675 | 45,796 | 46,550 | 45,647 | ||||||||||||
Diluted | 48,286 | 47,754 | 48,268 | 47,732 |